Needle-free injection of basal insulin improves fasting glucose variability as assessed by continuous glucose monitoring in T2DM: a prospective randomized multicenter open-label crossover study-Reference-Cited by-同舟云学术

Needle-free injection of basal insulin improves fasting glucose variability as assessed by continuous glucose monitoring in T2DM: a prospective randomized multicenter open-label crossover study

Published:2022-11-17 Issue:12 Volume:19 Page:1725-1734
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Sun Fei¹,Gao Bin¹,Yang Aili¹,Ren Lijun²,Xing Ying³,Ma Kaiyan⁴,Tian Li¹,Li Simin¹,Heng Chunni¹,Liu Hao⁵⁶,Zhou Jie⁷,Ji Qiuhe⁷^ORCID

Affiliation:

1. Department of Endocrinology, Tangdu Hospital, Air Force Medical University, Xi’an 710038, P.R. China

2. Department of Endocrinology, Xi’an International Medical Center Hospital, Xi’an 710100, P.R. China

3. Department of Endocrinology, Xi’an Daxing Hospital, Xi’an 710000, P.R. China

4. Department of Endocrinology, Shangluo Central Hospital, Shangluo 726000, Shaanxi, P.R. China

5. The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi’an Jiaotong University, Xi’an 710049, P.R. China

6. Bioinspired Engineering and Biomechanics Center (BEBC), Xi’an Jiaotong University, Xi’an 710049, P.R. China

7. Department of Endocrinology and Metabolism, Xijing Hospital, Air Force Medical University, Xi’an 710032, P.R. China

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2022.2147504

Reference34 articles.

1. Impact of Visit-to-Visit Glycemic Variability on the Risks of Macrovascular and Microvascular Events and All-Cause Mortality in Type 2 Diabetes: The ADVANCE Trial

2. Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2)

3. Fasting Glucose Variation Predicts Microvascular Risk in ACCORD and VADT

4. Day-to-day fasting self-monitored blood glucose variability is associated with risk of hypoglycaemia in insulin-treated patients with type 1 and type 2 diabetes: A post hoc analysis of the SWITCH Trials

5. Fasting plasma glucose variability and HbA1c are associated with peripheral artery disease risk in type 2 diabetes